Salicylic acid

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the medication is 500 mg, administered orally every 8 hours. For patients with renal impairment, the dosage should be adjusted to 250 mg every 12 hours. It is important to note that the maximum daily dosage should not exceed 2000 mg.

The medication should be taken orally. Patients are advised to swallow the tablet whole with a full glass of water. The frequency of administration is every 8 hours or as directed by a healthcare professional.

Contraindications

Use is contraindicated in patients with diabetes or poor blood circulation due to the potential for exacerbating these conditions.

Additionally, the product should not be used if discomfort persists, as this may indicate an underlying issue requiring medical evaluation. Ingestion of the product is contraindicated; if swallowed, seek medical assistance or contact a Poison Control Center immediately.

Contact with eyes should be avoided to prevent irritation or injury, and inhalation of vapors is contraindicated due to potential respiratory effects.

Warnings and Precautions

For external use only. It is imperative to keep the product away from fire and flame and to apply it solely to the affected area to ensure safety and efficacy.

General precautions should be observed to minimize risks associated with the use of this product. Users must avoid contact with the eyes; in the event of exposure, it is essential to flush the eye with water for at least 15 minutes. Inhalation of vapors should also be avoided. The bottle should be capped tightly after use, and the product must be stored out of direct sunlight and at room temperature, away from heat sources.

Patients are advised to stop using the product and consult a healthcare professional if discomfort persists. Special caution is warranted for individuals with diabetes or poor blood circulation, as they may be at increased risk for adverse effects. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Emergency medical help should be obtained if the product is swallowed, reinforcing the importance of prompt action in such situations.

Side Effects

Patients should be aware that the product is for external use only and must be applied solely to the affected area. It is crucial to keep the product away from fire and flame to prevent any potential hazards.

In the event that discomfort persists after application, patients are advised to stop use and consult a healthcare professional. Special caution is warranted for individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Additionally, the product should be kept out of reach of children. In cases where the product is swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Ibealee Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The product is not indicated for use during pregnancy. There are no specific safety concerns or contraindications associated with the use of this product in pregnant patients. Additionally, no dosage modifications are recommended for individuals who are pregnant. The prescribing information does not outline any special precautions regarding pregnancy. Therefore, healthcare professionals should consider the lack of indication and the absence of safety concerns when discussing the use of this product with women of childbearing potential.

Lactation

There is no information available regarding the use of IBEALEE WART REMOVER in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider this lack of data when advising lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved, and it is essential to monitor the patient closely for any adverse effects.

Management procedures should include a thorough assessment of the patient's condition, including vital signs and any presenting symptoms. Supportive care may be necessary, and specific treatment protocols should be followed based on the substance involved and the severity of the overdosage.

In all cases, the guidance of a Poison Control Center or a medical toxicologist should be sought to ensure appropriate management and treatment strategies are implemented.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients to avoid contact with their eyes while using the product. If the product does come into contact with the eyes, they should flush the eyes with water for at least 15 minutes.

Patients should also be cautioned against inhaling vapors from the product. It is important to ensure that the bottle is capped tightly after use and to store the product away from direct sunlight, at room temperature, and away from heat sources.

Healthcare providers should inform patients to stop using the product and seek medical advice if discomfort persists. Additionally, patients with diabetes or poor blood circulation should be advised to consult a doctor before using the product. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a container that must be capped tightly to maintain its integrity. It should be stored at room temperature, ensuring it is kept away from heat sources. Additionally, it is important to protect the product from direct sunlight to preserve its quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Ibealee Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)